Nearly 20 million measles deaths averted in Africa since 2000

Story: 2026 C.E.  |  Last updated: April 22, 2026

A sweeping new analysis by the World Health Organization and Gavi, the Vaccine Alliance, has found that measles vaccination programs across Africa have prevented approximately 19.5 million deaths since 2000 C.E. — the equivalent of saving roughly 800,000 lives every year for nearly a quarter century. The report, the first detailed continent-wide assessment of its kind, also found that more than 500 million children across Africa received protection through routine immunization over that same period.

At a glance

• Measles vaccination Africa: Coverage for the second dose of the measles-containing vaccine rose from just 5% in 2000 C.E. to 55% in 2024 C.E., with 44 African countries adding that second dose to their routine schedules.
• Supplemental immunization campaigns: More than 622 million vaccinations were delivered through targeted campaigns, helping cut measles deaths in the region by half and reducing overall cases by 40%.
• Vaccine-preventable diseases: Routine immunization schedules now protect against 13 diseases, up from eight in 2000 C.E., while meningitis deaths have fallen by 39% and the malaria vaccine has been introduced in 25 countries.

A generation of progress

The numbers behind this achievement are striking. In 2000 C.E., the second dose of measles vaccine reached just one in 20 African children. By 2024 C.E., that figure had grown more than tenfold. The transformation reflects two decades of sustained investment — in cold-chain infrastructure, community health workers, and the political will to treat childhood vaccination as a public health priority rather than an afterthought.

Three countries have now crossed the threshold into official elimination status. In 2025 C.E., Cabo Verde, Mauritius, and Seychelles became the first sub-Saharan African nations to achieve measles and rubella elimination — the gold standard in disease prevention. Nine additional countries reported consistently low measles incidence in 2023 C.E. and 2024 C.E., with fewer than five cases per million people.

Beyond measles, the analysis captures a broader public health transformation. Hepatitis B vaccination is now offered in 47 sub-Saharan countries, with 16 providing a birth dose. Thirty-three countries have introduced the rubella vaccine. Twenty-nine offer the human papillomavirus vaccine, which protects against cervical cancer. In 2024 C.E. alone, at least 1.9 million lives were saved through vaccination — with 42% of that total attributable to measles vaccines.

What made it work

No single factor explains the progress. It required a combination of consistent government commitment, international funding — Gavi has been a central financier for low-income countries — and repeated supplemental campaigns that reached children who had been missed by routine services. Community trust, built over years by local health workers, made it possible to reach populations that formal health systems often struggle to access.

Dr. Mohamed Janabi, WHO Regional Director for Africa, credited the collective effort but was direct about the limits of celebration. “Africa has made remarkable progress in less than a generation, expanding immunization and saving millions of young lives,” he said. “But the progress is uneven, and even slowing, leaving too many children unprotected as key targets are still missed.”

The analysis also highlights contributions from health workers in communities often absent from mainstream narratives — rural village vaccinators, cross-border campaign teams, and Indigenous community liaisons who made population-level coverage possible in remote and fragile contexts.

The unfinished work

For all the progress, Africa remains off track to meet the Immunization Agenda 2030 target of 90% coverage for key vaccines. Rapid population growth, fragile health systems, climate-related disruptions, humanitarian crises, and political instability all complicate the path forward. Coverage improvements have not been evenly distributed — children in the hardest-to-reach communities are still being missed, and that gap is widening immunization inequity within countries.

Gavi CEO Dr. Sania Nishtar acknowledged the tension plainly. “These immunisation outcomes reflect very different realities, and we have more work to do to ensure we are consistently able to reach children, even in the most fragile and remote contexts,” she said. Gavi’s Leap reform agenda aims to address this through more flexible, country-specific approaches designed to build sustainable, self-reliant programs rather than dependence on external intervention.

WHO and Gavi are also working to accelerate introduction of newer vaccines — including for malaria and HPV — while pressing governments to integrate immunization more deeply into primary health care rather than treating it as a parallel vertical program.

Why the milestone matters

Twenty million deaths averted is not an abstraction. It is the rough equivalent of every person in the state of New York — prevented from dying, most of them children under five. Measles is one of the most contagious diseases known to medicine, and before vaccines became widely available, it killed more children globally than almost any other single pathogen.

The WHO African Region analysis underscores something important: that sustained, coordinated investment in public health infrastructure — even imperfect and uneven — accumulates over time into outcomes that would have seemed almost unimaginable in 2000 C.E. The challenge now is ensuring that momentum doesn’t falter as population growth outpaces health system capacity, and as funding pressures test the commitments that made this progress possible.

For researchers and policymakers, the report also demonstrates the value of tracking immunization data rigorously across the continent. The UNICEF immunization program, which works alongside WHO and Gavi in many countries, has been part of building the data infrastructure that makes analyses like this possible. Understanding what worked — and where — is essential to replicating it. And the evidence is clear: when measles vaccination reaches children consistently and at scale, children live who would otherwise die.

That is not a small thing. It may be one of the most significant public health achievements of the 21st century so far.

Read more

For more on this story, see: WHO African Region

For more from Good News for Humankind, see:

• U.K. cancer death rates fall to their lowest level on record
• Ghana establishes a new marine protected area at Cape Three Points
• The Good News for Humankind archive on global health

About this article

• 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
• 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
• 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
• ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.